TFS Chemicals - Aspire
Pharma Focus America
Sino Biological - Cytokine

BioGenCell Announces the Launch of its Fifth Clinical Trial Site for Chronic Limb-Threatening Ischemia in the United States

Friday, December 08, 2023

BioGenCell, a leader in the field of personalized cell therapy solutions, is pleased to announce the commencement of its fifth Phase II clinical trial site in the United States at the University of Maryland Medical Center. This significant trial aims to reduce the need for amputation in patients suffering from Chronic Limb-Threatening Ischemia (CLTI). The University of Maryland Medical Center has joined this global, placebo-controlled trial to bring about transformative results for patients.

The prognosis for CLI patients is currently grim, with nearly 20% succumbing to the disease within a year of diagnosis, and 30% facing amputation. Unfortunately, almost 70% of those undergoing amputation do not survive beyond five years post-procedure.

BioGenCell's innovative, low-risk technology utilizes immune, stem, and progenitor cells from the patient's own blood through a simple procedure. When reinjected into the affected limb, these "trained" cells stimulate the formation of new, healthy blood vessels, restoring blood flow and potentially preventing amputation or even death, significantly improving the quality of life for patients. BioGenCell's previous clinical trials have shown promising long-term amputation-free survival rates.

"We are excited to embark on this journey with a reputable institution like the University of Maryland," said Dr. Yael Porat, BioGenCell co-founder and CEO. "Our goal is to provide tangible relief to individuals living with CLI."

Individuals living with CLTI, their friends and relatives, as well as interested physicians, are encouraged to visit www.biogencelltrial.com or contact the Study Coordinator (details) for more information on participating in this clinical trial.

 

Source: prnewswire.com

patheon - Mastering API production at every scaleWorld Vaccine Congress Europe 2024World Orphan Drug Congress 2024Future Labs Live USA 2024patheon - Revolutionizing PharmaHealthcare CNO SummitHealthcare CMO Summit